Once Monthly HIV Drug Combo Approved By FDA

U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus, reports NBC News.

The approval of the two-shot combo called Cabenuva is expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy. It’s a huge change from not long ago, when patients had to take multiple pills several times a day, carefully timed around meals.

“That will enhance quality of life” to need treatment just once a month, said Dr. Steven Deeks, an HIV specialist at the University of California, San Francisco, who has no ties to the drug’s makers. “People don’t want those daily reminders that they’re HIV infected.”

Cabenuva combines rilpivirine, sold as Edurant by Johnson & Johnson’s Janssen unit, and a new drug — cabotegravir, from ViiV Healthcare. They’re packaged together and given as separate shots once a month.

Dosing every two months is also being tested.

READ MORE HERE:

https://www.nbcnews.com/feature/nbc-out/fda-approves-1st-long-acting-hiv-drug-combo-monthly-shots-n1255291?fbclid=IwAR2SD4xHOVXz2ddXTxDIAoo28rS3jxvfg4CkGpbblCMAYjNhrGhZJ7sLnFA